Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours - Kashyap, R; Hofman, M S; Michael, M (Eur J Nucl Med Mol Imaging, 2015)
, et al.